Sec Form 4 Filing - Dunn Michael J. @ CalciMedica, Inc. /DE/ - 2023-03-20

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
Dunn Michael J.
 2. Issuer Name and Ticker or Trading Symbol
CalciMedica, Inc. /DE/ [ CALC] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
X __ Officer (give title below) _____ Other (specify below)
President and COO
(Last) (First) (Middle)
C/O CALCIMEDICA, INC., 505 COAST S. BLVD. #202 		3. Date of Earliest Transaction (MM/DD/YY)
03/20/2023
(Street)
LA JOLLA, CA92037 		4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
__ X __ Form filed by One Reporting Person
_____ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4) 		7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5) 		6. Date Exercisable and Expiration Date
(MM/DD/YY) 		7. Title and Amount of Underlying Securities
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4) 		10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4) 		11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (right to buy) $ 1.39 03/20/2023 A 11,761 ( 1 ) 10/01/2024 Common Stock 11,761 ( 2 ) 11,761 D
Employee Stock Option (right to buy) $ 2.44 03/20/2023 A 22,777 ( 1 ) 08/01/2028 Common Stock 22,777 ( 3 ) ( 4 ) 22,777 D
Employee Stock Option (right to buy) $ 2.44 03/20/2023 A 8,640 ( 5 ) 04/24/2029 Common Stock 8,640 ( 4 ) ( 6 ) 8,640 D
Employee Stock Option (right to buy) $ 6.6 03/20/2023 A 23,589 ( 7 ) 06/29/2030 Common Stock 23,589 ( 4 ) ( 8 ) 23,589 D
Employee Stock Option (right to buy) $ 7.99 03/20/2023 A 7,915 ( 9 ) 04/27/2031 Common Stock 7,915 ( 4 ) ( 10 ) 7,915 D
Employee Stock Option (right to buy) $ 7.99 03/20/2023 A 13,147 ( 1 ) 04/27/2031 Common Stock 13,147 ( 4 ) ( 11 ) 13,147 D
Employee Stock Option (right to buy) $ 7.99 03/20/2023 A 7,915 ( 9 ) 06/30/2031 Common Stock 7,915 ( 4 ) ( 10 ) 7,915 D
Employee Stock Option (right to buy) $ 10.42 03/20/2023 A 1,323 ( 1 ) 08/30/2032 Common Stock 1,323 ( 4 ) ( 12 ) 1,323 D
Employee Stock Option (right to buy) $ 10.42 03/20/2023 A 1,954 ( 1 ) 08/30/2032 Common Stock 1,954 ( 4 ) ( 13 ) 1,954 D
Employee Stock Option (right to buy) $ 17.34 03/20/2023 A 24,747 ( 14 ) 03/19/2033 Common Stock 24,747 ( 4 ) ( 15 ) 24,747 D
Employee Stock Option (right to buy) $ 17.34 03/20/2023 A 847 ( 14 ) 03/19/2023 Common Stock 847 ( 4 ) ( 16 ) 847 D
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Dunn Michael J.
C/O CALCIMEDICA, INC.
505 COAST S. BLVD. #202
LA JOLLA, CA92037		 President and COO
Signatures
By John Dunn, Attorney-in-Fact 03/22/2023
Signature of Reporting Person Date
Explanation of Responses: ( 1 )Immediately exercisable.
( 2 )Received in exchange for a stock option to acquire 408,402 shares of common stock of CalciMedica, Inc. ("CalciMedica") pursuant to an Agreement and Plan of Merger and Reorganization (the "Merger Agreement") by and among CalciMedica, the Issuer and Camaro Merger Sub, Inc., a wholly-owned subsidiary of the Issuer ("Merger Sub"). Under the terms of the Merger Agreement, on March 20, 2023, Merger Sub merged with and into CalciMedica (the "Merger"), with CalciMedica surviving the Merger as a wholly-owned subsidiary of the Issuer. Upon the closing of the Merger, each outstanding option to purchase shares of CalciMedica common stock was assumed by the Issuer and converted into an option to purchase the Issuer's common stock. Subsequent to the Merger, the name of the Issuer was changed from Graybug Vision, Inc. to CalciMedica, Inc.
( 3 )Received in exchange for a stock option to acquire 790,880 shares of common stock of CalciMedica pursuant to the Merger Agreement.
( 4 )Upon the closing of the Merger, each outstanding option to purchase shares of CalciMedica common stock was assumed by the Issuer and converted into an option to purchase the Issuer's common stock.
( 5 )25% of the shares subject to the option vested on April 30, 2020 and the balance of the shares vest in a series of thirty-six (36) successive equal monthly installments thereafter.
( 6 )Received in exchange for a stock option to acquire 300,000 shares of common stock of CalciMedica pursuant to the Merger Agreement.
( 7 )25% of the shares subject to the option vested on June 30, 2020 and the balance of the shares vest in a series of thirty-six (36) successive equal monthly installments thereafter.
( 8 )Received in exchange for a stock option to acquire 819,064 shares of common stock of CalciMedica pursuant to the Merger Agreement.
( 9 )Beginning on February 22, 2021, the shares subject to the option vest in a series of forty-eight (48) successive equal monthly installments.
( 10 )Received in exchange for a stock option to acquire 274,848 shares of common stock of CalciMedica pursuant to the Merger Agreement.
( 11 )Received in exchange for a stock option to acquire 456,522 shares of common stock of CalciMedica pursuant to the Merger Agreement.
( 12 )Received in exchange for a stock option to acquire 45,955 shares of common stock of CalciMedica pursuant to the Merger Agreement.
( 13 )Received in exchange for a stock option to acquire 67,873 shares of common stock of CalciMedica pursuant to the Merger Agreement.
( 14 )Beginning on November 22, 2022, the shares subject to the option vest in a series of forty-eight (48) successive equal monthly installments.
( 15 )Received in exchange for a stock option to acquire 859,280 shares of common stock of CalciMedica pursuant to the Merger Agreement.
( 16 )Received in exchange for a stock option to acquire 29,420 shares of common stock of CalciMedica pursuant to the Merger Agreement.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.